Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer

By sjmartinez • October 11, 2024

Chow F, Lamoureux F, Moriceau G. Editorial: Developing next-generation therapeutics to defeat mutation-driven cancer. Front Immunol. 2024 Sep 26;15:1487952. doi: 10.3389/fimmu.2024.1487952. PMID: 39391312; PMCID: PMC11464455.

Tags: ADC, antibody drug conjugate, Cancer, combination therapy, Dermatology, Drug resistance, immunotherapy, next generation therapeutics, Publications, targeted therapy

Contact Dermatitis in the United States: A Population-Based Study on Patient Visit Characteristics and Treatment Prescription Patterns

Hao A, Yu RP, Kikuchi R, Sadrolashrafi K, Guo L, Yamamoto RK, Tolson H, Yee D, Bilimoria S, Pourali SP, Adler BL, Armstrong AW. Contact[...]

Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report

Biba U, Poppens MJ, Collier EK, Cheng K. Radiation therapy for a case of poikilodermatous plaques in an otherwise healthy young man: A case report.[...]

Short Snips: YouTube Shorts Recommendations for Hair Loss and Alopecia

Ko M, Kim D, Newsom E, Goh C. Short Snips: YouTube Shorts Recommendations for Hair Loss and Alopecia. J Cosmet Dermatol. 2024 Oct 3. doi:[...]